November 2016 - Evolution Biotechnologies
0
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

14 Nov

Posted at 15:01h in News by
0 Likes

Bedford, UK, and Austin, Texas; November 14th 2016 Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announces the release of a video interview with its Chief Officer, Dr. David Harper, conducted by Dr. Robert Atterbury of Nottingham University. The interview forms part of the University’s online course on Antimicrobial Resistance in the Food Chain, which will launch on Monday 14th November: www.futurelearn.com/courses/antimicrobial-resistance-food-chain/. The interview can also be viewed by clicking on the following link  https://www.youtube.com/watch?v=DxKhlc4adKk. About Evolution Biotechnologies Evolution Biotechnologies (UK company 09473027 / US company 6050853) has been established to extend the application...

10 Nov

Posted at 11:45h in News by
0 Likes

Bedford, UK, and Austin, Texas; November 10th 2016 Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announces a presentation by its Chief Officer, Dr. David Harper. The presentation, entitled “Bacteriophage therapy – Still promising but not (yet) delivering" is to be given on Thursday 10th November via webex at the virtual conference held by Euroscicon on Developing antibiotic alternatives: A discussion of new approaches to overcoming antimicrobial resistance. About Evolution Biotechnologies Evolution Biotechnologies (UK company 09473027 / US company 6050853) has been established to extend the application of biological control from its agricultural roots into...